In today's rapidly changing and highly competitive business world, it is vital for investors and industry enthusiasts to carefully assess companies. In this article, we will perform a comprehensive industry comparison, evaluating Eli Lilly and Co (NYSE:LLY) against its key competitors in the Pharmaceuticals industry. By analyzing important financial metrics, market position, and growth prospects, we aim to provide valuable insights for investors and shed light on company's performance within the industry.
Eli Lilly and Co Background
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
Company | P/E | P/B | P/S | ROE | EBITDA (in billions) | Gross Profit (in billions) | Revenue Growth |
---|---|---|---|---|---|---|---|
Eli Lilly and Co | 134.51 | 68.82 | 20.65 | 19.91% | $3.03 | $7.57 | 28.1% |
Novo Nordisk A/S | 50.13 | 39.09 | 18.06 | 22.01% | $28.51 | $55.85 | 36.95% |
Johnson & Johnson | 30.55 | 5.56 | 4.78 | 5.78% | $6.82 | $14.6 | 7.3% |
Merck & Co Inc | 885.64 | 8.36 | 5.25 | -3.11% | $-0.77 | $10.72 | 5.78% |
AstraZeneca PLC | 34.75 | 5.24 | 4.51 | 2.52% | $2.18 | $9.72 | 7.29% |
Novartis AG | 24.37 | 4.38 | 4.48 | 19.99% | $4.18 | $8.75 | 7.39% |
Pfizer Inc | 72.41 | 1.70 | 2.58 | -3.62% | $-1.77 | $6.69 | -41.34% |
Sanofi SA | 20.59 | 1.49 | 2.40 | -0.75% | $0.42 | $8.15 | 6.5% |
Bristol-Myers Squibb Co | 13.80 | 3.66 | 2.46 | 6.03% | $4.45 | $8.73 | 0.62% |
GSK PLC | 14.27 | 5.20 | 2.32 | 2.64% | $1.16 | $5.63 | 9.16% |
Zoetis Inc | 35.80 | 16.63 | 9.82 | 10.42% | $0.83 | $1.49 | 8.48% |
Takeda Pharmaceutical Co Ltd | 39.45 | 1.03 | 1.68 | 1.53% | $314.89 | $731.71 | 1.33% |
Viatris Inc | 246.60 | 0.72 | 0.96 | -3.7% | $-0.07 | $1.6 | -1.0% |
Dr Reddy's Laboratories Ltd | 20.20 | 3.93 | 3.89 | 5.29% | $22.42 | $42.2 | 6.57% |
Jazz Pharmaceuticals PLC | 19.08 | 1.94 | 2.19 | 2.61% | $0.29 | $0.9 | 4.1% |
Average | 107.69 | 7.07 | 4.67 | 4.83% | $27.4 | $64.77 | 4.22% |